The Why
Being overweight affects conditions such as asthma, sleep apnea, diabetes, cardiovascular disease, osteoarthritis, back pain, and obesity hypoventilation syndrome. Adding new drug therapies to treatment protocols is showing promising results for millions of people, including participants of weight loss clinical trials.
We’ve conducted clinical trials for new weight loss drug therapies that are helping patients achieve impactful results.
- Semaglutide approved for weight loss by the FDA December 2017